Costs of Telaprevir-based Triple Therapy for Hepatitis C: $189,000 per Sustained Virologic Response

INTRODUCTION: In registration trials, triple therapy with telaprevir (TVR), pegylated-interferon (IFN), and ribavirin (RBV) achieved sustained virological response (SVR) rates between 64–75%, but the clinical effectiveness and economic burdens of this treatment in real-world practice remain to be de...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Bichoupan, Kian, Martel-Laferriere, Valerie, Sachs, David, Ng, Michel, Schonfeld, Emily A., Pappas, Alexis, Crismale, James, Stivala, Alicia, Khaitova, Viktoriya, Gardenier, Donald, Linderman, Michael, Perumalswami, Ponni V., Schiano, Thomas D., Odin, Joseph A., Liu, Lawrence, Moskowitz, Alan J., Dieterich, Douglas T., Branch, Andrea D.
格式: Artigo
語言:Inglês
出版: 2014
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4190678/
https://ncbi.nlm.nih.gov/pubmed/25065814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27340
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍